 | • レポートコード：MRC2-11QY10757 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は局所止血剤のグローバル市場について調査・分析したレポートです。種類別（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他）市場規模、用途別（病院、外科センター、ナーシングホーム）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別局所止血剤の競争状況、市場シェア ・世界の局所止血剤市場：種類別市場規模 2015年-2020年（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他） ・世界の局所止血剤市場：種類別市場規模予測 2021年-2026年（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他） ・世界の局所止血剤市場：用途別市場規模 2015年-2020年（病院、外科センター、ナーシングホーム） ・世界の局所止血剤市場：用途別市場規模予測 2021年-2026年（病院、外科センター、ナーシングホーム） ・北米の局所止血剤市場分析：米国、カナダ ・ヨーロッパの局所止血剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの局所止血剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の局所止血剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの局所止血剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ethicon、Pfizer、Baxter International、C. R. Bard、The Medicines Company、Anika Therapeutics、Advanced Medical Solutions、Integra LifeSciences、B Braun Melsungen、Gelita Medical、Equimedical、Vascular Solutions、Marine Polymer Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,
Market Analysis and Insights: Global Topical Hemostatic Agents Market
The global Topical Hemostatic Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Topical Hemostatic Agents Scope and Market Size
Topical Hemostatic Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Topical Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Topical Hemostatic Agents market is segmented into
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application, the Topical Hemostatic Agents market is segmented into
Hospitals
Surgical Centers
Nursing Homes
Regional and Country-level Analysis
The Topical Hemostatic Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Topical Hemostatic Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Topical Hemostatic Agents Market Share Analysis
Topical Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Topical Hemostatic Agents business, the date to enter into the Topical Hemostatic Agents market, Topical Hemostatic Agents product introduction, recent developments, etc.
The major vendors covered:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
1 Study Coverage
1.1 Topical Hemostatic Agents Product Introduction
1.2 Market Segments
1.3 Key Topical Hemostatic Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type
1.4.2 Gelation Sponge
1.4.3 Oxidized Regenerated Cellulose Based Hemostats
1.4.4 Others
1.5 Market by Application
1.5.1 Global Topical Hemostatic Agents Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Surgical Centers
1.5.4 Nursing Homes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Topical Hemostatic Agents Market Size, Estimates and Forecasts
2.1.1 Global Topical Hemostatic Agents Revenue 2015-2026
2.1.2 Global Topical Hemostatic Agents Sales 2015-2026
2.2 Global Topical Hemostatic Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Topical Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Topical Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Topical Hemostatic Agents Competitor Landscape by Players
3.1 Topical Hemostatic Agents Sales by Manufacturers
3.1.1 Topical Hemostatic Agents Sales by Manufacturers (2015-2020)
3.1.2 Topical Hemostatic Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Topical Hemostatic Agents Revenue by Manufacturers
3.2.1 Topical Hemostatic Agents Revenue by Manufacturers (2015-2020)
3.2.2 Topical Hemostatic Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Topical Hemostatic Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Topical Hemostatic Agents Revenue in 2019
3.2.5 Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Topical Hemostatic Agents Price by Manufacturers
3.4 Topical Hemostatic Agents Manufacturing Base Distribution, Product Types
3.4.1 Topical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Topical Hemostatic Agents Product Type
3.4.3 Date of International Manufacturers Enter into Topical Hemostatic Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Topical Hemostatic Agents Market Size by Type (2015-2020)
4.1.1 Global Topical Hemostatic Agents Sales by Type (2015-2020)
4.1.2 Global Topical Hemostatic Agents Revenue by Type (2015-2020)
4.1.3 Topical Hemostatic Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Topical Hemostatic Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Topical Hemostatic Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Topical Hemostatic Agents Revenue Forecast by Type (2021-2026)
4.2.3 Topical Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Topical Hemostatic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Topical Hemostatic Agents Market Size by Application (2015-2020)
5.1.1 Global Topical Hemostatic Agents Sales by Application (2015-2020)
5.1.2 Global Topical Hemostatic Agents Revenue by Application (2015-2020)
5.1.3 Topical Hemostatic Agents Price by Application (2015-2020)
5.2 Topical Hemostatic Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Topical Hemostatic Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Topical Hemostatic Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Topical Hemostatic Agents Price Forecast by Application (2021-2026)
6 North America
6.1 North America Topical Hemostatic Agents by Country
6.1.1 North America Topical Hemostatic Agents Sales by Country
6.1.2 North America Topical Hemostatic Agents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Topical Hemostatic Agents Market Facts & Figures by Type
6.3 North America Topical Hemostatic Agents Market Facts & Figures by Application
7 Europe
7.1 Europe Topical Hemostatic Agents by Country
7.1.1 Europe Topical Hemostatic Agents Sales by Country
7.1.2 Europe Topical Hemostatic Agents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Topical Hemostatic Agents Market Facts & Figures by Type
7.3 Europe Topical Hemostatic Agents Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Topical Hemostatic Agents by Region
8.1.1 Asia Pacific Topical Hemostatic Agents Sales by Region
8.1.2 Asia Pacific Topical Hemostatic Agents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Topical Hemostatic Agents Market Facts & Figures by Type
8.3 Asia Pacific Topical Hemostatic Agents Market Facts & Figures by Application
9 Latin America
9.1 Latin America Topical Hemostatic Agents by Country
9.1.1 Latin America Topical Hemostatic Agents Sales by Country
9.1.2 Latin America Topical Hemostatic Agents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Topical Hemostatic Agents Market Facts & Figures by Type
9.3 Central & South America Topical Hemostatic Agents Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Topical Hemostatic Agents by Country
10.1.1 Middle East and Africa Topical Hemostatic Agents Sales by Country
10.1.2 Middle East and Africa Topical Hemostatic Agents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Topical Hemostatic Agents Market Facts & Figures by Type
10.3 Middle East and Africa Topical Hemostatic Agents Market Facts & Figures by Application
11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Description and Business Overview
11.1.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ethicon Topical Hemostatic Agents Products Offered
11.1.5 Ethicon Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Topical Hemostatic Agents Products Offered
11.2.5 Pfizer Related Developments
11.3 Baxter International
11.3.1 Baxter International Corporation Information
11.3.2 Baxter International Description and Business Overview
11.3.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Baxter International Topical Hemostatic Agents Products Offered
11.3.5 Baxter International Related Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Corporation Information
11.4.2 C. R. Bard Description and Business Overview
11.4.3 C. R. Bard Sales, Revenue and Gross Margin (2015-2020)
11.4.4 C. R. Bard Topical Hemostatic Agents Products Offered
11.4.5 C. R. Bard Related Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Description and Business Overview
11.5.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 The Medicines Company Topical Hemostatic Agents Products Offered
11.5.5 The Medicines Company Related Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Corporation Information
11.6.2 Anika Therapeutics Description and Business Overview
11.6.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Anika Therapeutics Topical Hemostatic Agents Products Offered
11.6.5 Anika Therapeutics Related Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Corporation Information
11.7.2 Advanced Medical Solutions Description and Business Overview
11.7.3 Advanced Medical Solutions Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Advanced Medical Solutions Topical Hemostatic Agents Products Offered
11.7.5 Advanced Medical Solutions Related Developments
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Corporation Information
11.8.2 Integra LifeSciences Description and Business Overview
11.8.3 Integra LifeSciences Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Integra LifeSciences Topical Hemostatic Agents Products Offered
11.8.5 Integra LifeSciences Related Developments
11.9 B Braun Melsungen
11.9.1 B Braun Melsungen Corporation Information
11.9.2 B Braun Melsungen Description and Business Overview
11.9.3 B Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 B Braun Melsungen Topical Hemostatic Agents Products Offered
11.9.5 B Braun Melsungen Related Developments
11.10 Gelita Medical
11.10.1 Gelita Medical Corporation Information
11.10.2 Gelita Medical Description and Business Overview
11.10.3 Gelita Medical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Gelita Medical Topical Hemostatic Agents Products Offered
11.10.5 Gelita Medical Related Developments
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Description and Business Overview
11.1.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ethicon Topical Hemostatic Agents Products Offered
11.1.5 Ethicon Related Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Corporation Information
11.12.2 Vascular Solutions Description and Business Overview
11.12.3 Vascular Solutions Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Vascular Solutions Products Offered
11.12.5 Vascular Solutions Related Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Corporation Information
11.13.2 Marine Polymer Technologies Description and Business Overview
11.13.3 Marine Polymer Technologies Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Marine Polymer Technologies Products Offered
11.13.5 Marine Polymer Technologies Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Topical Hemostatic Agents Market Estimates and Projections by Region
12.1.1 Global Topical Hemostatic Agents Sales Forecast by Regions 2021-2026
12.1.2 Global Topical Hemostatic Agents Revenue Forecast by Regions 2021-2026
12.2 North America Topical Hemostatic Agents Market Size Forecast (2021-2026)
12.2.1 North America: Topical Hemostatic Agents Sales Forecast (2021-2026)
12.2.2 North America: Topical Hemostatic Agents Revenue Forecast (2021-2026)
12.2.3 North America: Topical Hemostatic Agents Market Size Forecast by Country (2021-2026)
12.3 Europe Topical Hemostatic Agents Market Size Forecast (2021-2026)
12.3.1 Europe: Topical Hemostatic Agents Sales Forecast (2021-2026)
12.3.2 Europe: Topical Hemostatic Agents Revenue Forecast (2021-2026)
12.3.3 Europe: Topical Hemostatic Agents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Topical Hemostatic Agents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Topical Hemostatic Agents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Topical Hemostatic Agents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Topical Hemostatic Agents Market Size Forecast by Region (2021-2026)
12.5 Latin America Topical Hemostatic Agents Market Size Forecast (2021-2026)
12.5.1 Latin America: Topical Hemostatic Agents Sales Forecast (2021-2026)
12.5.2 Latin America: Topical Hemostatic Agents Revenue Forecast (2021-2026)
12.5.3 Latin America: Topical Hemostatic Agents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Topical Hemostatic Agents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Topical Hemostatic Agents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Topical Hemostatic Agents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Topical Hemostatic Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Topical Hemostatic Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Topical Hemostatic Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Topical Hemostatic Agents Market Segments
Table 2. Ranking of Global Top Topical Hemostatic Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Topical Hemostatic Agents Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Gelation Sponge
Table 5. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
Table 6. Major Manufacturers of Others
Table 7. Global Topical Hemostatic Agents Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Topical Hemostatic Agents Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Topical Hemostatic Agents Sales by Regions 2015-2020 (K Units)
Table 10. Global Topical Hemostatic Agents Sales Market Share by Regions (2015-2020)
Table 11. Global Topical Hemostatic Agents Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Topical Hemostatic Agents Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Topical Hemostatic Agents Sales Share by Manufacturers (2015-2020)
Table 14. Global Topical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Topical Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Topical Hemostatic Agents as of 2019)
Table 16. Topical Hemostatic Agents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Topical Hemostatic Agents Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Topical Hemostatic Agents Price (2015-2020) (USD/Unit)
Table 19. Topical Hemostatic Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Topical Hemostatic Agents Product Type
Table 21. Date of International Manufacturers Enter into Topical Hemostatic Agents Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Topical Hemostatic Agents Sales by Type (2015-2020) (K Units)
Table 24. Global Topical Hemostatic Agents Sales Share by Type (2015-2020)
Table 25. Global Topical Hemostatic Agents Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Topical Hemostatic Agents Revenue Share by Type (2015-2020)
Table 27. Topical Hemostatic Agents Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Topical Hemostatic Agents Sales by Application (2015-2020) (K Units)
Table 29. Global Topical Hemostatic Agents Sales Share by Application (2015-2020)
Table 30. North America Topical Hemostatic Agents Sales by Country (2015-2020) (K Units)
Table 31. North America Topical Hemostatic Agents Sales Market Share by Country (2015-2020)
Table 32. North America Topical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Topical Hemostatic Agents Revenue Market Share by Country (2015-2020)
Table 34. North America Topical Hemostatic Agents Sales by Type (2015-2020) (K Units)
Table 35. North America Topical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 36. North America Topical Hemostatic Agents Sales by Application (2015-2020) (K Units)
Table 37. North America Topical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 38. Europe Topical Hemostatic Agents Sales by Country (2015-2020) (K Units)
Table 39. Europe Topical Hemostatic Agents Sales Market Share by Country (2015-2020)
Table 40. Europe Topical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Topical Hemostatic Agents Revenue Market Share by Country (2015-2020)
Table 42. Europe Topical Hemostatic Agents Sales by Type (2015-2020) (K Units)
Table 43. Europe Topical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 44. Europe Topical Hemostatic Agents Sales by Application (2015-2020) (K Units)
Table 45. Europe Topical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Topical Hemostatic Agents Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Topical Hemostatic Agents Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Topical Hemostatic Agents Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Topical Hemostatic Agents Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Topical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Topical Hemostatic Agents Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Topical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 54. Latin America Topical Hemostatic Agents Sales by Country (2015-2020) (K Units)
Table 55. Latin America Topical Hemostatic Agents Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Topical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Topical Hemostatic Agents Revenue Market Share by Country (2015-2020)
Table 58. Latin America Topical Hemostatic Agents Sales by Type (2015-2020) (K Units)
Table 59. Latin America Topical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 60. Latin America Topical Hemostatic Agents Sales by Application (2015-2020) (K Units)
Table 61. Latin America Topical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Topical Hemostatic Agents Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Topical Hemostatic Agents Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Topical Hemostatic Agents Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 70. Ethicon Corporation Information
Table 71. Ethicon Description and Major Businesses
Table 72. Ethicon Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Ethicon Product
Table 74. Ethicon Recent Development
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Major Businesses
Table 77. Pfizer Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Product
Table 79. Pfizer Recent Development
Table 80. Baxter International Corporation Information
Table 81. Baxter International Description and Major Businesses
Table 82. Baxter International Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Baxter International Product
Table 84. Baxter International Recent Development
Table 85. C. R. Bard Corporation Information
Table 86. C. R. Bard Description and Major Businesses
Table 87. C. R. Bard Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. C. R. Bard Product
Table 89. C. R. Bard Recent Development
Table 90. The Medicines Company Corporation Information
Table 91. The Medicines Company Description and Major Businesses
Table 92. The Medicines Company Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. The Medicines Company Product
Table 94. The Medicines Company Recent Development
Table 95. Anika Therapeutics Corporation Information
Table 96. Anika Therapeutics Description and Major Businesses
Table 97. Anika Therapeutics Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Anika Therapeutics Product
Table 99. Anika Therapeutics Recent Development
Table 100. Advanced Medical Solutions Corporation Information
Table 101. Advanced Medical Solutions Description and Major Businesses
Table 102. Advanced Medical Solutions Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Advanced Medical Solutions Product
Table 104. Advanced Medical Solutions Recent Development
Table 105. Integra LifeSciences Corporation Information
Table 106. Integra LifeSciences Description and Major Businesses
Table 107. Integra LifeSciences Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Integra LifeSciences Product
Table 109. Integra LifeSciences Recent Development
Table 110. B Braun Melsungen Corporation Information
Table 111. B Braun Melsungen Description and Major Businesses
Table 112. B Braun Melsungen Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. B Braun Melsungen Product
Table 114. B Braun Melsungen Recent Development
Table 115. Gelita Medical Corporation Information
Table 116. Gelita Medical Description and Major Businesses
Table 117. Gelita Medical Topical Hemostatic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Gelita Medical Product
Table 119. Gelita Medical Recent Development
Table 120. Equimedical Corporation Information
Table 121. Equimedical Description and Major Businesses
Table 122. Equimedical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Equimedical Product
Table 124. Equimedical Recent Development
Table 125. Vascular Solutions Corporation Information
Table 126. Vascular Solutions Description and Major Businesses
Table 127. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Vascular Solutions Product
Table 129. Vascular Solutions Recent Development
Table 130. Marine Polymer Technologies Corporation Information
Table 131. Marine Polymer Technologies Description and Major Businesses
Table 132. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Marine Polymer Technologies Product
Table 134. Marine Polymer Technologies Recent Development
Table 135. Global Topical Hemostatic Agents Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global Topical Hemostatic Agents Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Topical Hemostatic Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Topical Hemostatic Agents Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Topical Hemostatic Agents Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: Topical Hemostatic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Topical Hemostatic Agents Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: Topical Hemostatic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Topical Hemostatic Agents Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: Topical Hemostatic Agents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Topical Hemostatic Agents Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: Topical Hemostatic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Topical Hemostatic Agents Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: Topical Hemostatic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Topical Hemostatic Agents Players
Table 153. Topical Hemostatic Agents Customers List
Table 154. Topical Hemostatic Agents Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Topical Hemostatic Agents Product Picture
Figure 2. Global Topical Hemostatic Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Gelation Sponge Product Picture
Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 5. Others Product Picture
Figure 6. Global Topical Hemostatic Agents Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Surgical Centers
Figure 9. Nursing Homes
Figure 10. Topical Hemostatic Agents Report Years Considered
Figure 11. Global Topical Hemostatic Agents Market Size 2015-2026 (US$ Million)
Figure 12. Global Topical Hemostatic Agents Sales 2015-2026 (K Units)
Figure 13. Global Topical Hemostatic Agents Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Topical Hemostatic Agents Sales Market Share by Region (2015-2020)
Figure 15. Global Topical Hemostatic Agents Sales Market Share by Region in 2019
Figure 16. Global Topical Hemostatic Agents Revenue Market Share by Region (2015-2020)
Figure 17. Global Topical Hemostatic Agents Revenue Market Share by Region in 2019
Figure 18. Global Topical Hemostatic Agents Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Topical Hemostatic Agents Revenue in 2019
Figure 20. Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Topical Hemostatic Agents Sales Market Share by Type (2015-2020)
Figure 22. Global Topical Hemostatic Agents Sales Market Share by Type in 2019
Figure 23. Global Topical Hemostatic Agents Revenue Market Share by Type (2015-2020)
Figure 24. Global Topical Hemostatic Agents Revenue Market Share by Type in 2019
Figure 25. Global Topical Hemostatic Agents Market Share by Price Range (2015-2020)
Figure 26. Global Topical Hemostatic Agents Sales Market Share by Application (2015-2020)
Figure 27. Global Topical Hemostatic Agents Sales Market Share by Application in 2019
Figure 28. Global Topical Hemostatic Agents Revenue Market Share by Application (2015-2020)
Figure 29. Global Topical Hemostatic Agents Revenue Market Share by Application in 2019
Figure 30. North America Topical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Topical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Topical Hemostatic Agents Sales Market Share by Country in 2019
Figure 33. North America Topical Hemostatic Agents Revenue Market Share by Country in 2019
Figure 34. U.S. Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Topical Hemostatic Agents Market Share by Type in 2019
Figure 39. North America Topical Hemostatic Agents Market Share by Application in 2019
Figure 40. Europe Topical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Topical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Topical Hemostatic Agents Sales Market Share by Country in 2019
Figure 43. Europe Topical Hemostatic Agents Revenue Market Share by Country in 2019
Figure 44. Germany Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Topical Hemostatic Agents Market Share by Type in 2019
Figure 55. Europe Topical Hemostatic Agents Market Share by Application in 2019
Figure 56. Asia Pacific Topical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Topical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Topical Hemostatic Agents Sales Market Share by Region in 2019
Figure 59. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Region in 2019
Figure 60. China Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Topical Hemostatic Agents Market Share by Type in 2019
Figure 83. Asia Pacific Topical Hemostatic Agents Market Share by Application in 2019
Figure 84. Latin America Topical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Topical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Topical Hemostatic Agents Sales Market Share by Country in 2019
Figure 87. Latin America Topical Hemostatic Agents Revenue Market Share by Country in 2019
Figure 88. Mexico Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Topical Hemostatic Agents Market Share by Type in 2019
Figure 95. Latin America Topical Hemostatic Agents Market Share by Application in 2019
Figure 96. Middle East and Africa Topical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Topical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Country in 2019
Figure 100. Turkey Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Topical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Topical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Topical Hemostatic Agents Market Share by Type in 2019
Figure 107. Middle East and Africa Topical Hemostatic Agents Market Share by Application in 2019
Figure 108. North America Topical Hemostatic Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Topical Hemostatic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Topical Hemostatic Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Topical Hemostatic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Topical Hemostatic Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Topical Hemostatic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Topical Hemostatic Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Topical Hemostatic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Topical Hemostatic Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Topical Hemostatic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…- 局所ドラッグデリバリーシステムの世界市場（～2026年） Market Analysis and Insights: Global Topical Drug Delivery System Market The global Topical Drug Delivery System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Topical Drug Delivery System Scope and Market Size Topica…
- 局所用ニキビ治療の世界市場（～2026年） Acne is the most common skin disease and topical treatment can reduce the severity and frequency of acne growth. Market Analysis and Insights: Global Topical Use Acne Treatment Market The global Topical Use Acne Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million …
- 局所疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Topical Pain Management Therapeutics Market The global Topical Pain Management Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Topical Pain Management Therapeutics Scop…
- 局所ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Topical Drug Delivery Market The global Topical Drug Delivery market size is projected to reach US$ 80690 million by 2026, from US$ 77970 million in 2020, at a CAGR of 3.2%% during 2021-2026. Global Topical Drug Delivery Scope and Market Size Topical Drug Deliver…